Open AccessPD28-11 NOVEL DRUGS FOR TARGETING HISTONE DEACETYLASE INHIBITOR TO CELLS CONTAINING ANDROGEN RECEPTORS: ANALYSIS OF IN VIVO EFFECTIVENESS AGAINST HUMAN PROSTATE CANCER.
Author(s) -
Carrie Sun,
Rebecca S. Arnold,
David A. Gaul,
Subhasish Tapadar,
Berkley E. Gryder,
Adegboyega K. Oyelere,
John A. Petros
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.398
Subject(s) - lncap , androgen receptor , medicine , histone deacetylase , prostate cancer , in vivo , antiandrogens , cancer research , histone deacetylase inhibitor , vorinostat , pharmacology , cancer , histone , biology , biochemistry , gene , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom